1.
Okamura K, Matsushima M, Takamiya Y, Okuda T, Sako H, Udo A, et al. Addition of Sacubitril/Valsartan to Mineralocorticoid Receptor Antagonist Therapy in Primary Aldosteronism: Effects on Plasma Aldosterone Concentration and Plasma Renin Activity. J Clin Med Res [Internet]. 2024 Oct. 31 [cited 2024 Dec. 10];16(10):509-17. Available from: https://jocmr.elmerjournals.com/jocmr/article/view/6058